Detalhe da pesquisa
1.
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium.
J Med Genet
; 55(1): 15-20, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490613
2.
Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Ann Surg Oncol
; 23(10): 3232-8, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338744
3.
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
Cancer
; 120(13): 2000-5, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711224